Free
$0Free plan available.
iCAD is a global leader in providing clinically proven AI-powered breast health solutions, aiming to create a world where cancer can’t hide. Their ProFound Breast Health Suite includes solutions for cancer detection, density assessment, and risk evaluation, backed by science and clinical evidence. iCAD's AI-powered solutions improve patient outcomes and save lives by helping radiologists find more invasive cancers earlier, reduce reading time, and provide consistent density scoring. They also offer solutions for colon health and support various partners in the industry.
To use iCAD's solutions, healthcare providers can integrate the ProFound Breast Health Suite into their existing clinical workflows. Patients can access information regarding AI-powered mammograms and available resources on the iCAD website. Additionally, interested parties can request a demo to see the solutions in action.
The ProFound Breast Health Suite is a collection of AI-powered tools from iCAD designed for cancer detection, breast density assessment, and risk evaluation.
No, ProFound AI Risk is CE Marked and Health Canada Licensed; it is not FDA cleared and is available in the United States for investigational use only.
iCAD's AI-powered technology assists radiologists in detecting invasive cancers earlier, decreasing reading times, and delivering consistent density scoring to enhance patient outcomes.
ProFound AI delivers objective, reliable, and consistent density scoring, helping clinicians standardize breast density assessments to support more informed treatment planning.
Free plan available.